Ovid Therapeutics Inc.
IPOHome - Ovid Therapeutics
- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- ovidrx.com
- Total Funding
- $216.0M
- Last Round
- $60.0M Venture RoundMar 2026
- Rounds
- 3
- Type
- Public
About
Biopharmaceutical company dedicated to reducing seizures and improving lives of people with rare neurological disorders.
Summary
Ovid Therapeutics Inc. is a healthtech company based in New York, United States, founded in 2014. It has raised $216.0M in total across 3 rounds, most recently a $60.0M Venture Round round in Mar 2026. Investors include Point72, Coastlands Capital and Janus Henderson Investors.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Mar 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Similar Companies
BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...
Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...
Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.
Biopharmaceutical oncology company focused on discovery, development, and commercialization of ca...
Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...
Research-based development stage biopharmaceutical company that discovers and develops innovative...